# Top 35 Medical Device Startup Investors in Australia in May 2026

## Brandon Capital Partners
- Type: VC Fund
- Location: Melbourne, Victoria, Australia
- Relevant deals: 7
- Stages: Series A, Seed, Series B
- Focus: Biotechnology, Health Care, Medical

Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients.

## Medical Research Commercialisation Fund (MRCF)
- Type: VC Fund
- Location: Melbourne, Victoria, Australia
- Relevant deals: 6
- Stages: Series A, Seed, Series B
- Focus: Biotechnology, Health Care, Medical

Medical Research Commercialisation Fund (MRCF) provides dedicated, investment funding to support the commercialisation of early-stage medical research discoveries that originate from its member institutes. The collaborative nature of the MRCF seeks to foster best practice in the commercialisation of medical innovations.

## Artesian VC
- Type: VC Fund
- Location: Melbourne, Victoria, Australia
- Relevant deals: 4
- Stages: Seed, Series A, Pre-Seed
- Focus: Software, Artificial Intelligence, Information Technology

Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.

## Melbourne Angels
- Type: VC Fund
- Location: Melbourne, Victoria, Australia
- Relevant deals: 4
- Stages: Angel, Seed
- Focus: Biotechnology, Information Technology, Manufacturing

Melbourne Angels was formed in Melbourne, Australia in early 2007. Melbourne Angels is the leading group of private investors in Victoria who actively invest in early stage and growth technology companies.The group has a strong and experienced core of members that generate deal flow, are experienced in evaluation of business propositions and actas mentors for the other members and the entrepreneurs. The members vary in age, gender, ethnicity, profession and type of experience. All members have experience of success at being entrepreneurial.This award winning group is consistently one of the most active startup investors in the country.

## Uniseed Ventures
- Type: VC Fund
- Location: Brisbane, Queensland, Australia
- Relevant deals: 2
- Stages: Series A, Seed
- Focus: Biotechnology, Manufacturing, Health Care

Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.

## Allan Moss
- Type: Angel
- Location: Sydney, New South Wales, Australia
- Relevant deals: 2
- Stages: Series A, Seed
- Focus: Health Care, Medical Device, Biotechnology

Allan Moss acts an adviser to Anchorage’s Investment Committee. Currently Principal of Allan Moss Investments, a private investment company, Allan retired from the role of Managing Director and Chief Executive Officer of Macquarie Group in May 2008. He was with Macquarie Group for 31 years and served as CEO from 1993 to his retirement in2008. He was also a non- executive director of CSR Ltd from 1996 to 2001.Allan graduated from Sydney University in Arts with a major in Economics and in Laws with Honours. He is also a graduate of Harvard University with a Masters Degree in Business Administration with High Distinction. Allan has received numerous industry awards and recognitions. He was twice named by Barron’s Magazine as one of the 30 most respected CEOs in the world (2006, 2007). He was appointed an Officer of the Order of Australia in 2005.

## Global Health Investment Fund (GHIF)
- Type: VC Fund
- Location: New York, New York, United States
- Relevant deals: 2
- Stages: Series B, Series C
- Focus: Health Care, Biotechnology, Medical Device

The Global Health Investment Fund (GHIF) is a $108 million social impact investment fund designed to provide financing to advance the development of drugs, vaccines, diagnostics and other interventions against diseases that disproportionately burden low- and middle-income countries. GHIF supports late-stage innovations for public health challengessuch as malaria, pre-eclampsia, cholera, HIV and river blindness, with an emphasis on infectious diseases and maternal/infant health issues that cause significant morbidity and mortality in resource-limited settings. GHIF may also make investments that improve or expand access to existing products—such as developing pediatric formulations of approved therapeutics or improving the stability of widely-used global health vaccines.As an investment fund with a limited time-horizon, GHIF seeks opportunities that have a high probability of successful commercialization within two or three years. Products with “dual market” potential are of greatest interest; i.e., those that will have a clear impact on public health in developing countries but also have value in high-income countries. High-volume / low-margin products, such as essential vaccines, are also of significant interest.GHIF employs a range of investment structures including mezzanine debt, convertible debt, preferred equity and project financing with an average investment target of approximately $10 million per project. Each GHIF project must advance the Fund’s social impact objectives and demonstrate the ability to achieve commercial success.

## Regal Funds Management
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 2
- Stages: Series B, Convertible Note
- Focus: Software, Financial Services, FinTech

Regal Funds Management was founded in 2004 by Andrew and Philip King. Regal utilises a long/short investment strategy and performs investment management and investment advisory services to a number of Australian Unit Trusts and Cayman Island Companies.

## Starfish Ventures
- Type: VC Fund
- Location: Melbourne, Victoria, Australia
- Relevant deals: 1
- Stages: Series A, Series B
- Focus: Software, Enterprise Software, Information Technology

Starfish Ventures is an Australian venture capital firm focused on information technology, life sciences, and clean technology companies.

## BridgeLane Capital
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 1
- Stages: Seed, Series B
- Focus: Software, Financial Services, Health Care

The BridgeLane Group is a privately-owned asset management firm specialising in the agricultural, real estate and innovation sectors. A significant global player in agriculture with a multi-decade record in large scale farming, the Group has a proud history in residential property development, comme

## Transition Level Investments
- Type: VC Fund
- Location: Brisbane, Queensland, Australia
- Relevant deals: 1
- Stages: Seed, Pre-Seed, Series A
- Focus: SaaS, Artificial Intelligence, Software

Founded by Steve Baxter, Transition Level Investments provides equity capital and operational expertise across Seed and Series A rounds to Australian companies.
Our team focuses on a company-growth approach, adding value by assisting founders to build their expertise, expand their team, build product, scale locally and globally to position for asuccessful exit. We have a track record of identifying investment opportunities in the Australian market and helping enable global growth.

## CP Ventures
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 1
- Stages: Seed, Pre-Seed, Series A
- Focus: Software, Artificial Intelligence, Machine Learning

CP Ventures is a VC fund that invests internationally in early stage, highly scalable, breakthrough technology companies driven by the 4IR

## Andrew R Banks
- Type: Angel
- Location: Sydney, New South Wales, Australia
- Relevant deals: 1
- Stages: Seed
- Focus: Grocery, Medical, Health Care

Andrew R Banks

## HealthCare Ventures
- Type: VC Fund
- Location: Cambridge, Massachusetts, United States
- Relevant deals: 1
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Pharmaceutical

HealthCare Ventures is a leading life science venture capital firm investing in pre-clinical or early clinical stage, focused companies with potential to transform patient care.

## UniSA Ventures
- Type: VC Fund
- Relevant deals: 1
- Stages: Seed
- Focus: Software, Health Care, Biotechnology

UniSA Ventures is the technology commercialisation and investment management company of the University of South Australia (UniSA).

## Playford Capital
- Type: VC Fund
- Location: Adelaide, South Australia, Australia
- Relevant deals: 1
- Stages: Series A, Series B
- Focus: Health Care, Biotechnology, Medical Device

Playford Capital is a venture capital arm of South Australian Government Financing Authority specializing in investments in start-ups, early venture, mid venture, late venture stages, and growth capital.

## Grand Challenges Canada
- Type: VC Fund
- Location: Toronto, Ontario, Canada
- Relevant deals: 1
- Stages: Grant, Seed, Debt Financing
- Focus: Health Care, Medical Device, Biotechnology

Grand Challenges Canada is dedicated to supporting Bold Ideas with Big Impact® in global health. They are funded by the Government of Canada and they fund innovators in low- and middle-income countries (LMICs) and Canada. The bold ideas they support integrate science and technology, social and business innovation – they call this IntegratedInnovation®. They focus on bringing successful innovation to scale, catalyzing sustainability and impact. They have a determined focus on results, and on saving and improving lives.Grand Challenges Canada works closely with Canada’s International Development Research Centre (IDRC), the Canadian Institutes of Health Research (CIHR) and Global Affairs Canada to catalyze scale, sustainability and impact. Grand Challenges Canada takes an evidence-based approach to development innovation to save and improve lives in LMICs. They are a platform for development innovation in Maternal, Newborn and Child Health (MNCH) through their Saving Lives at Birth, Saving Brains and MNCH Stars in Global Health programs. They are also focused on helping the poorest and most vulnerable populations, for example those who suffer from mental illness.Since their launch in 2010, Grand Challenges Canada has supported a pipeline of over 700 projects in more than 80 countries. Their investments are producing results: Thousands of lives have been saved and over two hundred and eighty thousand lives have been improved, thus far. By 2030, these innovations have the potential to save hundreds of thousands of lives and improve millions of lives.

## Right Click Capital
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 1
- Stages: Seed, Series A
- Focus: Software, Artificial Intelligence, SaaS

Right Click Capital - Australian Venture Capital Firm

## Powerhouse Ventures
- Type: VC Fund
- Location: Oakland, California, United States
- Relevant deals: 1
- Stages: Seed, Series A, Pre-Seed
- Focus: Software, Energy, Solar

Powerhouse Ventures
backs entrepreneurs building the digital infrastructure for rapid decarbonization.

## Microsoft for Startups
- Type: VC Fund
- Location: Redmond, Washington, United States
- Relevant deals: 1
- Stages: Seed, Grant
- Focus: Software, Information Technology, SaaS

Microsoft for Startups is a global program designed to help startups scale with free access to Azure cloud and a streamlined path into selling alongside Microsoft and our vast partner ecosystem.

## South Australian Venture Capital Fund
- Type: VC Fund
- Location: Adelaide, South Australia, Australia
- Relevant deals: 1
- Stages: Series A, Series B
- Focus: Health Care, Biotechnology, SaaS

South Australian Venture Capital Fund - helping build dynamic and innovative South Australian startups / scaleups and accelerate their growth to a national and global scale.

## OneVentures
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 1
- Stages: Series A, Debt Financing
- Focus: Software, Health Care, Information Technology

OneVentures is one of Australia’s leading venture capital firms, with over $330M in funds under management. But they do more than invest. They take companies to that all important next stage, by actively shaping their future. They apply their years of international experience, operational and executional expertise to accelerate the growth of theirportfolio companies. A global growth focus drives their investment selection with their current portfolio including companies with truly innovative products tackling multi-billion-dollar problems, from needle-free vaccinations to virtual communications to adaptive e-learning.

## Horizons Ventures
- Type: VC Fund
- Location: Hong Kong, Hong Kong Island, Hong Kong
- Relevant deals: 1
- Stages: Series A, Series B, Seed
- Focus: Biotechnology, Artificial Intelligence, Software

Investing in the deep science and technology that can propel humanity towards a radically better future.

## Breakthrough Victoria
- Type: VC Fund
- Location: Melbourne, Victoria, Australia
- Relevant deals: 1
- Stages: Series A, Seed, Series B
- Focus: Quantum Computing, Software, Training

Independent investment company managing the $2 billion Breakthrough Victoria Fund to make Victoria a global innovation leader.

## Ramsay Health Care
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 1
- Stages: Series A
- Focus: Medical, Health Care, Medical Device

Ramsay Health Care provides health care services to public and private patients. Its health care services comprise day surgery procedures and complex surgeries, as well as psychiatric care and rehabilitation services. It operates approximately 235 hospitals and day surgery facilities with approximately 25,000 beds in Australia, the United Kingdom,France, Indonesia, Malaysia, Maldives, and Italy. Paul Ramsay founded Ramsay Health Care in 1964. It has its headquarters in Sydney in Australia.

## Skip Capital
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 1
- Stages: Series A, Seed, Series B
- Focus: Software, SaaS, Artificial Intelligence

Skip Capital is a private investment fund investing in technology and infrastructure

## Blackbird Ventures
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 1
- Stages: Seed, Series A, Series B
- Focus: Software, SaaS, Information Technology

Blackbird is a venture capital fund based in Australia and New Zealand. We invest in every type of technology from software to space, unified by the biggest of ambitions.

## Sydney Angels
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 1
- Stages: Seed, Angel
- Focus: Software, SaaS, Apps

Sydney Angels is a not-for-profit angel investment membership organisation. Since our establishment in 2008, they have stayed true to our mission of supporting the early-stage ecosystem by running processes and events that connect our investing members with promising early-stage companiesThey believe that encouraging smart investment in startupcompanies will benefit both our members’ portfolios and Australia’s emergent innovation economy.They see this as the ultimate win-win situation. Sydney Angels is led by an elected committee of ten volunteers who meet weekly. It is supported by an operations manager and alliance partners.

## VU Venture Partners
- Type: VC Fund
- Location: San Francisco, California, United States
- Relevant deals: 1
- Stages: Seed, Series A
- Focus: Software, Health Care, Machine Learning

A multi-stage investment fund focused on Consumer, Enterprise, Fintech, Frontier, Healthcare, & PropTech

## Versant Ventures
- Type: VC Fund
- Location: Menlo Park, California, United States
- Relevant deals: 1
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Medical

Versant partners with exceptional entrepreneurs to build and fund breakthrough biotechnology companies around the globe.

## Terra Rossa Capital
- Type: VC Fund
- Location: Adelaide, South Australia, Australia
- Relevant deals: 1
- Stages: Series A, Series B
- Focus: Health Care, Biotechnology, Medical Device

Terra Rossa Capital Pty Ltd operates as a venture capital fund. The Company invests in life science companies. Terra Rossa Capital serves clients in Australia.

## Future of Healthcare Fund - Australian Unity
- Type: VC Fund
- Relevant deals: 1
- Stages: Series A
- Focus: Health Care, Medical Device

A fund focused on delivering long term capital growth whilst increasing the wellbeing of Australians by investing in the future healthcare needs of Australians. 

## Victoria University of Wellington
- Type: VC Fund
- Location: Wellington, Wellington, New Zealand
- Relevant deals: 1

A tradition of fostering strong global links in teaching and research and programmes of national significance and international quality.

## Dexcom Ventures
- Type: VC Fund
- Location: San Diego, California, United States
- Relevant deals: 1
- Focus: Sensor, Medical, Wearables

The inaugural fund will seek to identify and invest in opportunities to supplement growth in the core business and advance the development of adjacent technologies for the future.

## Artesian Investment
- Type: Angel
- Relevant deals: 1
- Stages: Pre-Seed, Seed, Series A
- Focus: Artificial Intelligence, Agriculture, Information Technology

Artesian Investment

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co